v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net Loss $ (9,422) $ (13,818)
Adjustments to reconcile loss to net cash used in operating activities:    
Depreciation 127 135
Share-based compensation 1,233 3,310
Warrants to service providers 43 209
Revaluation of warrants (10) (280)
Revaluation of convertible bonds (698) 27
Finance income (1,405) (207)
Change in operating assets and liabilities:    
Decrease in trade receivable 60 93
Decrease (increase) in prepaid expenses and other receivables (106) 1,070
Operating lease ROU assets and liabilities, net (19) 54
Increase (decrease) in trade payables (422) (70)
Increase in employees and payroll accruals 2,600 (3)
Increase in Derivative Liabilities 540 1,712
Increase (decrease) in accrued expenses and other payables (1,158) 1,546
Net cash used in operating activities (8,637) (6,222)
Cash flows from investing activities:    
Change in bank deposits (4,050) (53,180)
Purchase of property and equipment (25)
Net cash provided by (used in) investing activities (4,050) (53,205)
Cash flows from financing activities:    
Proceeds from issuance of ordinary shares, net of issuance costs 17,081 30,758
Issuance costs related to convertible bonds 21,696
Proceeds from exercise of warrants 493
Proceeds from exercise of options 47 438
Redemption of convertible notes upon voluntary conversion (233)
Net cash provided by financing activities 16,895 53,385
Increase (decrease) in cash, cash equivalents and restricted cash 4,208 (6,042)
Effect of exchange rate fluctuations on cash and cash equivalent 29 (542)
Cash, cash equivalents and restricted cash at the beginning of period 4,308 13,768
Cash, cash equivalents and restricted cash at the end of period $ 8,545 $ 7,184